Atlas Capital Advisors LLC Bristol Myers Squibb CO Transaction History
Atlas Capital Advisors LLC
- $788 Billion
- Q4 2024
A detailed history of Atlas Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 18,785 shares of BMY stock, worth $1.11 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
18,785
Previous 3,200
487.03%
Holding current value
$1.11 Million
Previous $166 Million
541.72%
% of portfolio
0.13%
Previous 0.03%
Shares
25 transactions
Others Institutions Holding BMY
# of Institutions
2,763Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.36 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.67 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.61 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.56 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...